Skip page header and navigation

Healthcare and Life Sciences businesses invited to sign up for free Sustainability Support Programme

Healthcare and Life Sciences businesses invited to sign up for free Sustainability Support Programme

Health and life sciences law firm Hill Dickinson and Yorkshire & Humber Academic Health Science Network (AHSN) have joined forces to launch a series of masterclasses for businesses operating in the healthcare and life sciences space. 

The jointly delivered Sustainability Support Programme is designed to help healthcare and life sciences businesses meet the challenge of improving their ESG-related performance in response to growing pressure from customers, investors and regulators.

The programme will take them through a series of masterclasses with a particular focus on carbon reduction and social value aspects of the ESG agenda. It will help them better understand and improve their ESG performance, in particular, to meet the requirements of the Greener NHS programme when delivering goods and services to the NHS and other, independent healthcare providers. The series will cover areas including carbon reduction datasets, public procurement requirements, low-carbon infrastructure and regulatory planning. 

Launch event: Wednesday 14 December

An in-person event to launch the Sustainability Support Programme will take place on Wednesday 14 December at Hill Dickinson’s London (City) offices. Businesses are invited to come along and find out more about the programme and how their business stands to benefit.

Announcing the launch, Jamie Foster, healthcare partner at Hill Dickinson, said: “Companies of all sizes are under increasing pressure to measure and improve their performance as part of the ESG agenda. In the healthcare industry that requirement is already impacting upon the entire NHS supply chain and equally in the supply chains of independent healthcare providers.

“In partnering with Yorkshire & Humber AHSN to deliver this series of joint masterclasses, we aim to support healthcare businesses that sell in to any larger client, whether public or private sector. The future success of businesses supplying or wishing to supply services to the NHS or similar independent providers will be predicated upon them understanding what changes they need to make and how to implement them – fast. We would urge anyone currently in this situation to take advantage of this free programme and sign up now.”

Kathy Scott, chief operating officer at Yorkshire and Humber AHSN added: “Our role as one of 15 AHSNs set up by NHS England is to operate as the key innovation arm of the NHS, helping to broker solutions that improve the delivery of health and care to patients and ultimately improve quality of life for the communities we represent.

“Sustainability is a key element of that and supporting businesses to develop competitive advantage benefits everyone. Those who sign up to the programme can look forward to gaining valuable knowledge and being able to network with like-minded stakeholders and other businesses facing similar challenges, including NHS partners.”

Details of the launch event and how to register here.

Our life sciences team provides practical, commercial legal advice to companies at all stages of development, from start-up to established multinational.

We support clients from an idea in a lab, to helping incorporate the company, raising capital, protecting and licensing intellectual property, signing strategic partnerships and, ultimately, commercialising life-changing treatments and technologies.

We also help clients navigate a legal and regulatory landscape that is continuously evolving in response to innovation as well as societal and ethical challenges.

Our interdisciplinary team blends insight and pragmatism to provide high-quality, trusted advice to some of the world’s leading life sciences companies.

Areas of expertise in which we work include biotech, pharma, cell and gene therapies, medtech and medical devices, medical cannabis and psychedelic medicine, agritech and alternative proteins, IVF and reproductive technologies and embryo research.